institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

CVS Health hikes 2025 forecast again, boosted by insurance, pharmacy businesses

WOONSOCKET, RHODE ISLAND, JUL 31 – Analysts hold mixed views on CVS Health's Q2 results, with earnings expected at $1.46 per share and revenue rising to $94.59 billion, reflecting varied price target adjustments.

  • CVS Health reported second-quarter 2025 earnings on July 31, showing adjusted EPS of $1.81 and revenue of $98.9 billion, both exceeding estimates.
  • The report followed a background of leadership changes with David Joyner as CEO, ongoing transformation, and elevated medical costs pressuring the insurance unit.
  • Revenue rose 8.4% year-over-year, driven by strong pharmacy and consumer wellness sales up 12%, while the insurance segment grew 11% despite higher medical benefit ratios.
  • Joyner attributed the earnings outperformance to advancements in pharmacy reimbursement and care delivery, highlighting the company’s continued achievement of strong financial performance for several quarters in a row.
  • CVS raised its outlook for adjusted earnings per share in fiscal 2025 to a range of $6.30 to $6.40, boosted its revenue projections, and aims to reduce costs by $2 billion, reflecting strong confidence despite challenges in the industry.
Insights by Ground AI
Does this summary seem wrong?

14 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 67% of the sources are Center
67% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Benzinga broke the news in New York, United States on Thursday, July 31, 2025.
Sources are mostly out of (0)